Deals Of The Week: Adimab/Mersana, Merck Serono/Prexton, Idenix/Novartis
Executive Summary
Enlight’s latest portfolio company, KNODE, soon will launch a search and networking platform to help researchers locate information, identify experts and form communities.
You may also be interested in...
Prexton Therapeutics’ Parkinson’s Assets First to Emerge from Merck KGAA Restructuring
Prexton Therapeutics will be headquartered at the Eclosion incubator facility in Geneva and will advance mGluR compounds for Parkinson’s from the Merck Serono portfolio.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.
CinFina Pushes Early Work In Obesity In Hopes Of A Deal
Emerging Company Profile: CinFina is advancing two novel mechanisms of action in obesity as monotherapies and in combination with GLP-1s.